undefined undefined
NaN.000
NaN.00%
I-Mab Adr (IMAB) has disclosed a new risk, in the Trade Secrets category. The e...
05-01 14:02
ROCKVILLE, Md., April 30, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercializat...
04-30 19:00
(文/王力 编辑/徐喆)4月26日,据国家药品监督管理局药品审评中心的公示,智飞生物(300122.SZ)关联公司重庆宸安生物制药有限公司的司美格鲁肽注射液临床...
04-26 22:08
热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! ...
04-16 23:41
Needham:重申天境生物(IMAB.US)评级,由买入调整至买入评级, 目标价6.00美元。
04-12 18:10
Needham analyst Gil Blum reiterates I-MAB (NASDAQ:IMAB) with a Buy and maintains $6 price target.
04-12 18:04
ROCKVILLE, Md., April 5, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly dif...
04-05 19:00
ROCKVILLE, Md., April 2, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB) a U.S.-based, global biotech company, exclusively focused on the development and potential commercializatio...
04-03 04:01
I-Mab Adr (IMAB) has released an update. I-Mab has announced significant change...
04-01 21:57
金融界3月30日消息,据CDE官网沟通交流公示,于3月30日收到天境生物科技(上海)有限公司申请的“II类会议”,当前状态“处理中”。 根据《药物研发与技术审评...
03-30 05:59